Alphabet-backed Isomorphic Labs raised $5B in a Series C round led by Greenoaks and Sequoia Capital. The AI drug-development developer is valued at about $50B. Funds will be used to advance the IsoDDE platform and internal oncology and immu
📈 AI · C-round funding for AI drug platform impact · 25
exa · contents-summary · 2026-11-17T14:41:34.707287Z 🌍